VRS: TSX-V

• Verisante is developing innovative systems for the early detection of many forms of cancer using technology developed by the BC Cancer Agency and the University of British Columbia.

• Verisante Aura™ is a novel imaging and spectroscopy device designed to aid in the early detection of all forms of skin cancer including melanoma, basal and squamous cell carcinoma.

• The Verisante Core™ series uses the platform technology behind Verisante Aura™ and an en- doscopic attachment to aid in the early detection of lung, colon, cervical and other cancers.

Fox News: Verisante CEO Thomas Braun discusses melanoma / skin cancer detection technology

Link to company website